Bridgeline Digital, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Bridgeline Digital, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Sep 30, 2018 | $13.57M | Dec 28, 2018 |
| FY2018 | Sep 30, 2017 | $16.29M | Dec 28, 2018 |
| FY2017 | Sep 30, 2016 | $15.90M | Dec 21, 2017 |
| FY2016 | Sep 30, 2015 | $19.22M | Dec 19, 2016 |
| FY2015 | Sep 30, 2014 | $23.74M | Dec 24, 2015 |
| FY2014 | Sep 30, 2013 | $24.51M | Dec 29, 2014 |
| FY2013 | Sep 30, 2012 | $26.30M | Dec 20, 2013 |
| FY2012 | Sep 30, 2011 | $26.27M | Dec 5, 2012 |
| FY2011 | Sep 30, 2010 | $23.56M | Dec 29, 2011 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $15.38M | Dec 19, 2025 |
| FY2025 | Sep 30, 2024 | $15.36M | Dec 19, 2025 |
| FY2024 | Sep 30, 2023 | $15.89M | Dec 26, 2024 |
| FY2023 | Sep 30, 2022 | $16.82M | Dec 27, 2023 |
| FY2022 | Sep 30, 2021 | $13.26M | Dec 21, 2022 |
| FY2021 | Sep 30, 2020 | $10.91M | Dec 20, 2021 |
| FY2020 | Sep 30, 2019 | $9.95M | Dec 23, 2020 |
| FY2019 | Sep 30, 2018 | $13.57M | Dec 27, 2019 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $10.24M | Dec 19, 2025 |
| FY2025 | Sep 30, 2024 | $10.43M | Dec 19, 2025 |
| FY2024 | Sep 30, 2023 | $10.87M | Dec 26, 2024 |
| FY2023 | Sep 30, 2022 | $11.70M | Dec 27, 2023 |
| FY2022 | Sep 30, 2021 | $8.73M | Dec 21, 2022 |
| FY2021 | Sep 30, 2020 | $6.40M | Dec 20, 2021 |
| FY2020 | Sep 30, 2019 | $4.59M | Dec 23, 2020 |
| FY2019 | Sep 30, 2018 | $6.82M | Dec 27, 2019 |
| FY2018 | Sep 30, 2017 | $9.13M | Dec 28, 2018 |
| FY2017 | Sep 30, 2016 | $8.61M | Dec 21, 2017 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | ($2.52M) | Dec 19, 2025 |
| FY2025 | Sep 30, 2024 | ($1.96M) | Dec 19, 2025 |
| FY2024 | Sep 30, 2023 | ($9.44M) | Dec 26, 2024 |
| FY2023 | Sep 30, 2022 | $2.15M | Dec 27, 2023 |
| FY2022 | Sep 30, 2021 | ($6.69M) | Dec 21, 2022 |
| FY2021 | Sep 30, 2020 | $326.0K | Dec 20, 2021 |
| FY2020 | Sep 30, 2019 | ($9.47M) | Dec 23, 2020 |
| FY2019 | Sep 30, 2018 | ($7.22M) | Dec 27, 2019 |
| FY2018 | Sep 30, 2017 | ($1.60M) | Dec 28, 2018 |
| FY2017 | Sep 30, 2016 | ($7.82M) | Dec 21, 2017 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | ($2.43M) | Dec 19, 2025 |
| FY2025 | Sep 30, 2024 | ($2.02M) | Dec 19, 2025 |
| FY2024 | Sep 30, 2023 | ($9.92M) | Dec 26, 2024 |
| FY2023 | Sep 30, 2022 | ($1.90M) | Dec 27, 2023 |
| FY2022 | Sep 30, 2021 | ($1.18M) | Dec 21, 2022 |
| FY2021 | Sep 30, 2020 | ($1.64M) | Dec 20, 2021 |
| FY2020 | Sep 30, 2019 | ($11.07M) | Dec 23, 2020 |
| FY2019 | Sep 30, 2018 | ($6.99M) | Dec 27, 2019 |
| FY2018 | Sep 30, 2017 | ($1.39M) | Dec 28, 2018 |
| FY2017 | Sep 30, 2016 | ($3.54M) | Dec 21, 2017 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $4.02M | Dec 19, 2025 |
| FY2025 | Sep 30, 2024 | $4.16M | Dec 19, 2025 |
| FY2024 | Sep 30, 2023 | $3.68M | Dec 26, 2024 |
| FY2023 | Sep 30, 2022 | $3.22M | Dec 27, 2023 |
| FY2022 | Sep 30, 2021 | $2.39M | Dec 21, 2022 |
| FY2021 | Sep 30, 2020 | $1.64M | Dec 20, 2021 |
| FY2020 | Sep 30, 2019 | $2.19M | Dec 23, 2020 |
| FY2019 | Sep 30, 2018 | $1.60M | Dec 27, 2019 |
| FY2018 | Sep 30, 2017 | $1.59M | Dec 28, 2018 |
| FY2017 | Sep 30, 2016 | $1.58M | Dec 21, 2017 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | ($1.10M) | Dec 19, 2025 |
| FY2025 | Sep 30, 2024 | ($765.0K) | Dec 19, 2025 |
| FY2024 | Sep 30, 2023 | $277.0K | Dec 26, 2024 |
| FY2023 | Sep 30, 2022 | ($134.0K) | Dec 27, 2023 |
| FY2022 | Sep 30, 2021 | ($989.0K) | Dec 21, 2022 |
| FY2021 | Sep 30, 2020 | ($498.0K) | Dec 20, 2021 |
| FY2020 | Sep 30, 2019 | ($4.20M) | Dec 23, 2020 |
| FY2019 | Sep 30, 2018 | ($1.11M) | Dec 27, 2019 |
| FY2018 | Sep 30, 2017 | ($940.0K) | Dec 28, 2018 |
| FY2017 | Sep 30, 2016 | ($2.68M) | Dec 21, 2017 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $18.0K | Dec 19, 2025 |
| FY2025 | Sep 30, 2024 | $29.0K | Dec 19, 2025 |
| FY2024 | Sep 30, 2023 | $25.0K | Dec 26, 2024 |
| FY2023 | Sep 30, 2022 | $117.0K | Dec 27, 2023 |
| FY2022 | Sep 30, 2021 | $79.0K | Dec 21, 2022 |
| FY2021 | Sep 30, 2020 | $0 | Dec 20, 2021 |
| FY2020 | Sep 30, 2019 | $20.0K | Dec 23, 2020 |
| FY2019 | Sep 30, 2018 | $35.0K | Dec 27, 2019 |
| FY2018 | Sep 30, 2017 | $47.0K | Dec 28, 2018 |
| FY2017 | Sep 30, 2016 | $23.0K | Dec 21, 2017 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $15.33M | Dec 19, 2025 |
| FY2025 | Sep 30, 2024 | $15.60M | Dec 19, 2025 |
| FY2024 | Sep 30, 2023 | $17.63M | Dec 26, 2024 |
| FY2023 | Sep 30, 2022 | $27.51M | Dec 27, 2023 |
| FY2022 | Sep 30, 2021 | $34.97M | Dec 21, 2022 |
| FY2021 | Sep 30, 2020 | $10.66M | Dec 20, 2021 |
| FY2020 | Sep 30, 2019 | $11.16M | Dec 23, 2020 |
| FY2019 | Sep 30, 2018 | $11.00M | Dec 27, 2019 |
| FY2018 | Sep 30, 2017 | $17.57M | Dec 28, 2018 |
| FY2017 | Sep 30, 2016 | $17.73M | Dec 21, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $5.76M | Dec 19, 2025 |
| FY2025 | Sep 30, 2024 | $5.60M | Dec 19, 2025 |
| FY2024 | Sep 30, 2023 | $6.17M | Dec 26, 2024 |
| FY2023 | Sep 30, 2022 | $7.16M | Dec 27, 2023 |
| FY2022 | Sep 30, 2021 | $17.39M | Dec 21, 2022 |
| FY2021 | Sep 30, 2020 | $6.30M | Dec 20, 2021 |
| FY2020 | Sep 30, 2019 | $7.36M | Dec 23, 2020 |
| FY2019 | Sep 30, 2018 | $6.58M | Dec 27, 2019 |
| FY2018 | Sep 30, 2017 | $6.30M | Dec 28, 2018 |
| FY2017 | Sep 30, 2016 | $6.23M | Dec 21, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $9.57M | Dec 19, 2025 |
| FY2025 | Sep 30, 2024 | $10.01M | Dec 19, 2025 |
| FY2025 | Sep 30, 2023 | $11.46M | Dec 19, 2025 |
| FY2024 | Sep 30, 2022 | $20.35M | Dec 26, 2024 |
| FY2023 | Sep 30, 2021 | $17.58M | Dec 27, 2023 |
| FY2022 | Sep 30, 2020 | $4.36M | Dec 21, 2022 |
| FY2021 | Sep 30, 2019 | $3.80M | Dec 20, 2021 |
| FY2020 | Sep 30, 2018 | $4.42M | Dec 23, 2020 |
| FY2019 | Sep 30, 2017 | $11.27M | Dec 27, 2019 |
| FY2018 | Sep 30, 2016 | $11.50M | Dec 28, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $8.47M | Dec 19, 2025 |
| FY2025 | Sep 30, 2024 | $8.47M | Dec 19, 2025 |
| FY2025 | Sep 30, 2023 | $8.47M | Dec 19, 2025 |
| FY2024 | Sep 30, 2022 | $15.99M | Dec 26, 2024 |
| FY2023 | Sep 30, 2021 | $15.99M | Dec 27, 2023 |
| FY2022 | Sep 30, 2020 | $5.56M | Dec 21, 2022 |
| FY2021 | Sep 30, 2019 | $5.56M | Dec 20, 2021 |
| FY2020 | Mar 13, 2019 | $1.51M | Dec 23, 2020 |
| FY2020 | Sep 30, 2018 | $7.78M | Dec 23, 2020 |
| FY2019 | Sep 30, 2017 | $12.64M | Dec 27, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | ($94.06M) | Dec 19, 2025 |
| FY2025 | Sep 30, 2024 | ($91.54M) | Dec 19, 2025 |
| FY2024 | Sep 30, 2023 | ($89.58M) | Dec 26, 2024 |
| FY2023 | Sep 30, 2022 | ($80.14M) | Dec 27, 2023 |
| FY2022 | Sep 30, 2021 | ($82.29M) | Dec 21, 2022 |
| FY2021 | Sep 30, 2020 | ($73.58M) | Dec 20, 2021 |
| FY2020 | Sep 30, 2019 | ($71.49M) | Dec 23, 2020 |
| FY2019 | Sep 30, 2018 | ($61.78M) | Dec 27, 2019 |
| FY2018 | Sep 30, 2017 | ($54.25M) | Dec 28, 2018 |
| FY2017 | Sep 30, 2016 | ($52.37M) | Dec 21, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $1.63M | Dec 19, 2025 |
| FY2025 | Sep 30, 2024 | $1.39M | Dec 19, 2025 |
| FY2024 | Sep 30, 2023 | $2.38M | Dec 26, 2024 |
| FY2023 | Sep 30, 2022 | $2.86M | Dec 27, 2023 |
| FY2022 | Sep 30, 2021 | $8.85M | Dec 21, 2022 |
| FY2021 | Sep 30, 2020 | $861.0K | Dec 20, 2021 |
| FY2020 | Sep 30, 2019 | $296.0K | Dec 23, 2020 |
| FY2019 | Sep 30, 2018 | $644.0K | Dec 27, 2019 |
| FY2019 | Sep 30, 2017 | $748.0K | Dec 27, 2019 |
| FY2018 | Sep 30, 2016 | $661.0K | Dec 28, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $326.0K | Dec 19, 2025 |
| FY2025 | Sep 30, 2024 | $500.0K | Dec 19, 2025 |
| FY2024 | Sep 30, 2023 | $700.0K | Dec 26, 2024 |
| FY2023 | Sep 30, 2022 | $1.00M | Dec 27, 2023 |
| FY2022 | Sep 30, 2021 | $1.90M | Dec 21, 2022 |
| FY2019 | Sep 30, 2018 | $3.59M | Dec 27, 2019 |
| FY2018 | Sep 30, 2017 | $2.50M | Dec 28, 2018 |
| FY2014 | Sep 30, 2014 | $6.92M | Dec 29, 2014 |
| FY2014 | Sep 30, 2013 | $5.89M | Dec 29, 2014 |
| FY2012 | Sep 30, 2012 | $4.40M | Dec 5, 2012 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | 0 | Dec 19, 2025 |
| FY2025 | Sep 30, 2024 | 0 | Dec 19, 2025 |
| FY2024 | Sep 30, 2023 | 0 | Dec 26, 2024 |
| FY2023 | Sep 30, 2022 | 0 | Dec 27, 2023 |
| FY2022 | Sep 30, 2021 | (1) | Dec 21, 2022 |
| FY2021 | Sep 30, 2020 | 0 | Dec 20, 2021 |
| FY2020 | Sep 30, 2019 | (8) | Dec 23, 2020 |
| FY2019 | Sep 30, 2018 | (89) | Dec 27, 2019 |
| FY2014 | Sep 30, 2014 | 0 | Dec 29, 2014 |
| FY2014 | Sep 30, 2013 | 0 | Dec 29, 2014 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | 0 | Dec 19, 2025 |
| FY2025 | Sep 30, 2024 | 0 | Dec 19, 2025 |
| FY2024 | Sep 30, 2023 | 0 | Dec 26, 2024 |
| FY2023 | Sep 30, 2022 | 0 | Dec 27, 2023 |
| FY2022 | Sep 30, 2021 | (1) | Dec 21, 2022 |
| FY2021 | Sep 30, 2020 | 0 | Dec 20, 2021 |
| FY2020 | Sep 30, 2019 | (8) | Dec 23, 2020 |
| FY2019 | Sep 30, 2018 | (89) | Dec 27, 2019 |
| FY2014 | Sep 30, 2014 | 0 | Dec 29, 2014 |
| FY2014 | Sep 30, 2013 | 0 | Dec 29, 2014 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | 12.22M | Dec 19, 2025 |
| FY2025 | Sep 30, 2024 | 10.42M | Dec 19, 2025 |
| FY2024 | Sep 30, 2023 | 10.42M | Dec 26, 2024 |
| FY2023 | Sep 30, 2022 | 10.42M | Dec 27, 2023 |
| FY2022 | Sep 30, 2021 | 10.19M | Dec 21, 2022 |
| FY2021 | Sep 30, 2020 | 4.42M | Dec 20, 2021 |
| FY2020 | Sep 30, 2019 | 2.80M | Dec 23, 2020 |
| FY2019 | Sep 30, 2018 | 84,005 | Dec 27, 2019 |
| FY2018 | Sep 30, 2017 | 4.20M | Dec 28, 2018 |
| FY2017 | Jul 24, 2017 | 4.20M | Dec 21, 2017 |